Belviq, Qsymia Clinic NYC

Belviq available at W8MD Medical Weight Loss Centers New York
Belviq available at W8MD Medical Weight Loss Centers New York Belviq is a prescription only weight loss medication and has to be evaluated by a trained and licensed physician familiar with obesity and the treatment of obesity. If you live close a W8MD medical weight loss center location, you may want to consider visiting the closest w8md center to be evaluated to see if Belviq, Qsymia or other weight loss medications or non medication VLCD or LCD diet might be right for you.
Belviq is a prescription only weight loss medication and has to be evaluated by a trained and licensed physician familiar with obesity and the treatment of obesity. If you live close to a W8MD medical weight loss center location, you may want to consider visiting the closest w8md center to be evaluated to see if Belviq, Qsymia or other weight loss medications or non medication VLCD or LCD diet might be right for you.

How Can W8MD Medical Weight Loss Centers Of America’s Program in NYC Help?

W8MD Medical Weight Loss Centers Of America announces that Belviq will be offered along with a low calorie diet at its unique insurance physician weight loss locations under the supervision of a trained obesity medicine physician. With offices in many states including New York, Pennsylvania, and New Jersey.

Price of Belviq
Arena (ARNA) has disclosed that the wholesale price for its anti-obesity drug Belviq is $199.50 for a 60 count bottle (a 1 month supply)

To help obese and overweight Americans who have been unsuccessful in getting their weight under control with diet and exercise, the Food and Drug Administration (FDA) has approved two new medications—the first drugs for long-term weight management that FDA has approved in 13 years.

Marketed as Belviq and Qsymia, these prescription medications would be taken for the rest of a person’s life. “For many people, obesity is a lifelong condition, but we don’t always think of it—or treat it—as such,” says Amy Egan, M.D., M.P.H., deputy director for safety in FDA’s Division of Metabolism and Endocrinology Products (DMEP).

Insurance medical weight loss
W8MD’s NYC insurance medical weight loss

“Qsymia and Belviq are considered life-long therapies in patients who respond to and tolerate them,” says Egan a first time that the FDA admitted weight loss a chronic problem and not like a short term flu type of problem.

The drugs are meant to be used in conjunction with a balanced diet and exercise, as per Mary Roberts, M.D., a medical officer in DMEP. “These drugs are another tool to be used by someone trying to reach and stay at a healthy weight,” she said.

Are You a Candidate For Belviq?
You may be a candidate for taking Belviq or Qsymia if you are at least 18 and:
• your body mass index (BMI) is 30 or greater (obese); or
• your BMI is 27 or greater (overweight) and you have at least one other weight-related condition.

Do not get pregnant on Qsymia

Women who are pregnant or thinking of becoming pregnant should not take either of these medications, Egan says, because
weight loss offers no potential benefit to a pregnant woman and can cause fetal harm. Qsymia carries a risk for birth defects (cleft lip with or without cleft palate) in infants exposed during the firs trimester of pregnancy.

How Does Belviq Work?
Belviq—the trade name for the drug lorcaserin— is a 10 mg tablet taken twice a day by mouth that works by activating a part of the brain that controls hunger.

Belviq was tested in three clinical trials that lasted from 52 to 104 weeks and included nearly 8,000 obese and overweight patients.

• The average weight loss for patients taking Belviq ranged from 3 to 3.7 percent over those taking a placebo.
• In studies of patients without type 2 diabetes, about 47 percent of patients lost at least 5 percent of their weight compared with 23 percent of patients treated with placebo.

Belviq should be discontinued if a patient fails to lose 5 percent of their weight after 12 weeks of treatment, as it is unlikely that continued treatment will be successful.

w8md weight loss reviews
w8md weight loss reviews
Cost of Belviq

The average cost of Belviq varies from $209.00 to $225.00 per month at most pharmacy retailers in the United States.

Coupon for Belviq

However, the pharmaceutical company offers a coupon that is available via W8MD medical weight loss centers offices that can bring the cost down to as low as $75.00 for certain patients with either no insurance or commercial insurance!

 

Unfortunately, these discount cards do not work for medicare / medicaid patients who might have to shell the full price or decide to not use insurance and go the cash route to get the discount!

Alternatives to Belviq: Qsymia, Contrave, Saxenda, Phentermine, Phentermine and Topiramate, Phendimetrazine, Tenuate etc.

Qsymia is a combination of two FDA-approved drugs: phentermine, an appetite suppressant that is traditionally the most commonly used weight loss diet pill, and topiramate, used to treat neuropathy, epilepsy and migraines.  It is believed that the combined weight loss is much higher compared to what is expected by individual components due to the synergistic action of these two weight loss medications.

How can W8MD medical weight loss centers in NYC help?

W8MD medical weight loss program in New York City can help you lose weight safely and effectively using non-surgical weight loss measures such as FDA approved weight loss medications, Very Low Calorie and Low Calorie Diets, along with instructions on proper physical activity, you can lose weight safely and effectively. Call 1-718-946-5500 to learn more. Limited acceptance due to popular demand!

Related articles for losing weight fast in New York City

Leave a Reply

Please log in using one of these methods to post your comment:

WordPress.com Logo

You are commenting using your WordPress.com account. Log Out / Change )

Twitter picture

You are commenting using your Twitter account. Log Out / Change )

Facebook photo

You are commenting using your Facebook account. Log Out / Change )

Google+ photo

You are commenting using your Google+ account. Log Out / Change )

Connecting to %s